Why so quiet?

Discussion in 'Valeant Pharmaceuticals' started by Anonymous, Aug 12, 2014 at 6:47 PM.

Tags: Add Tags
  1. Anonymous

    Anonymous Guest

    Just curious?
     

  2. Anonymous

    Anonymous Guest

    It is taking a while to count our debt...
     
  3. Anonymous

    Anonymous Guest

    We are trying to make our numbers. Allergan reps are starting $hit on Cafepharma all day.
     
  4. Anonymous

    Anonymous Guest

    Not so quiet anymore. Things seem to be tilting VRX's way
     
  5. Anonymous

    Anonymous Guest

    Not my opinion at all. We should have picked on a company that was not quite so healthy….
     
  6. Anonymous

    Anonymous Guest

    "picked on"? We are trying to buy a company. But rather than negotiate, the Allergan CEO engages in market manipulation of Valeant stock. Once their board is replaced with responsible people, we make our best offer. This is what Allergan shareholders want.
     
  7. Anonymous

    Anonymous Guest

    Ha, ha, ha.

    Sun Tsu would say the easiest and most efficient way to victory is to allow your enemy to crumble from within. PS1 is being managed to their last breath. Cheers
     
  8. Anonymous

    Anonymous Guest

    1.) Nobody really buys the Allergan market manipulation theory, not even Ackman. And if there is to be a discussion about market manipulation, we need to go back to the Granddaddy of them all in this saga, which is the unethical and perhaps (will-be-ruled) illegal market manipulation done by Ackman and Pearson and the PS 1 Fund to roll up AGN stock without alerting the SEC.

    2.) There will be a long, lllonnggggg wait until Valeant and Pershing Square load the Allergan Board with their "responsible people", the same responsible people who plan to throw Allergan's long-term research projects and future gains under the wheels of Pearson's Valeant-paid/US taxpayer written-off $65,000,000 private jet.

    Remember, the Dec 18 shareholder meeting only gets to potentially vote current Allergan directors off the island. It does not get to vote in the Ackman Politburo. This nightmare will continue well into 2015. The "best offer" from an Ackman/Pearson board will massively undervalue Allergan's assets; they have no reason to pay full freight for a company they plan to significantly gut upon acquisition.

    3.) "This is what the shareholders want." No, they do not. There is a wide universe of Allergan shareholders, and stakeholders as well, beyond the activist, short-term hedge funds (and that includes T.Rowe Price which is functioning as a hedge fund). And these Allergan shareholders and stakeholders are well in agreement that Valeant management of Allergan assets would be devastating to the community from which they have built their longlasting trust.
     
  9. Anonymous

    Anonymous Guest

    The share holders will decide. Share holders want the short term gains so they can buy companies that do not have this drama around it. Sell Allergan stock to the highest bidder and then buy a good company like Tesla, Apple, or Corning. Why stick around. Put out a for sale sign to bring in more bidders. Maybe a half-way ethical company will join the bidding.
     
  10. Anonymous

    Anonymous Guest

    Salix is the way to go. No more worries, strong GI products.